Glycot Therapeutics
Business Services · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4991 Wild Olive Ct, Ellicott City, Maryl...Phone Number
(410) 707-3183Website
www.glycot.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Glycot Therapeutics
GlycoT Therapeutics specializes in innovative chemoenzymatic glycosylation technology aimed at glycoengineering therapeutic proteins, particularly monoclonal antibodies, to enhance their efficacy. The company also produces enzymes, oligosaccharides, glycopeptides, and other glycoprotein products for research applications in disease diagnosis and glycobiology. Their clients include pharmaceutical companies and research institutions seeking advanced glycoengineering solutions. GlycoT has established partnerships and licensing agreements with notable organizations, including Daiichi Sankyo and Genovis.Explore more
Popular Searchesglycot therapeutics LLCGlycoTGlycoT Therapeutics LLC Signs Sublicense Agreementglycot therapeutics llcGetSIC Code 87,873NAICS Code 54,541Show moreGlycot Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Glycot Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Glycot Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Glycot Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Glycot Therapeutics has new funding data
Click to see if Glycot Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Glycot Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Glycot Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at Glycot Therapeutics
Website visits: Recent activity has been detected on your website
Check out if Glycot Therapeutics is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Glycot Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Glycot Therapeutics
Compare insights from companies similar to Glycot Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Glycot Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Glycot Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Glycot Therapeutics.
Glycot Therapeutics Tech Stack
A closer look at the technologies used by Glycot Therapeutics
Glycot Therapeutics News & Media
GlycoT Therapeutics Grants Sublicense of Glycoengineering Technology to Daiichi Sankyo
BALTIMORE, Sept. 14, 2020 /PRNewswire/ -- GlycoT Therapeutics LLC, a UM Ventures start-up company based on intellectual property (IP) developed at the University of Maryland, Baltimore (UMB) and University of Maryland, College Park (UMCP), has executed a sublicense agreement for its...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Glycot Therapeutics
Sign Up For FreeTo access detailed company insights
GlycoT Therapeutics specializes in innovative chemoenzymatic glycosylation technology aimed at glycoengineering therapeutic proteins, particularly monoclonal antibodies, to enhance their efficacy. The company also produces enzymes, oligosaccharides, glycopeptides, and other glycoprotein products for research applications in disease diagnosis and gl... Read More
